يعرض 1 - 10 نتائج من 325 نتيجة بحث عن '"Stentoft, Jesper"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية
  6. 6
  7. 7
  8. 8
    كتاب

    المساهمون: Hauge, Ellen-Margrethe, Ainsworth, Mark Andrew, Poulsen, Susanne Dam

    المصدر: Kjeldsen , L , Abildgaard , N , Andersen , M K , Brown , P D N , El-Galaly , T , Frederiksen, H , Glenthøj , A , Grønbæk , K , Hansen , M B , Hutchings , M , Leinøe , E B , Niemann , C U , Overgaard , U , Sengeløv , H & Stentoft , J 2024 , Blodsygdomme . i E-M Hauge , M A Ainsworth & S D Poulsen (red) , Medicinsk Kompendium . 20. udg , Munksgaard , København , s. 1415-1520 . < https://medicinskkompendium-20udg.digi.munksgaard.dk/?id=298Test >

  9. 9
    مؤتمر
  10. 10
    دورية أكاديمية

    المساهمون: TRIMM - Translational Immunology Research Program, Medicum, University of Helsinki, Department of Computer Science, Department of Clinical Chemistry and Hematology, HUS Comprehensive Cancer Center, Hematologian yksikkö, Integrins in immunity, Department of Oncology, Helsinki University Hospital Area, Clinicum, Digital Precision Cancer Medicine (iCAN)

    وصف الملف: application/pdf

    العلاقة: The authors would like to acknowledge the patients, study nurses, and other personnel in the clinical centers for their participation in this trial. The trial was supported by a grant from Bristol-Myers Squibb to the Norwegian University of Science and Technology (NTNU) . In addition, this work was supported by the Nordic Cancer Union, Academy of Finland, the Signe and Ane Gyllenberg Foundation, the Helsinki Institute of Life Science, Cancer Foundation Finland, the EUTOS project for CML 2018, ERA -Net ERACoSysMed JTC-2 project "prediCt,"the Relander Foundation, and the Finnish Cancer Institute. JH was supported by the Finnish Hematology Association, the Blood Disease Research Foundation, the Helsinki Institute for Life Science, the Biomedicum Helsinki Foundation, the Finnish Medical Foundation, the K. Albin Johansson Foundation, the Kaute Foundation, and the Emil Aaltonen Foundation.; Huuhtanen , J , Ilander , M , Yadav , B , Dufva , O M J , Lähteenmäki , H , Kasanen , T , Klievink , J , Olsson-Strömberg , U , Stentoft , J , Richter , J , Koskenvesa , P , Hoglund , M , Söderlund , S , Dreimane , A , Porkka , K , Gedde-Dahl , T , Gjertsen , B T , Stenke , L , Myhr-Eriksson , K , Markevarn , B , Lubking , A , Dimitrijevic , A , Udby , L , Bjerrum , O W , Hjorth-Hansen , H & Mustjoki , S 2022 , ' IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia ' , Journal of Clinical Investigation , vol. 132 , no. 17 , 152585 . https://doi.org/10.1172/JCI152585Test; ORCID: /0000-0002-0816-8241/work/120006643; ORCID: /0000-0003-4112-5902/work/120007003; ORCID: /0000-0002-5408-1948/work/156153387; http://hdl.handle.net/10138/348451Test; 038d91e6-96b2-46be-82df-a21105711bb7; 000853413700005